Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
MobileODT is an AI-based health-tech company that develops medical device technologies for cervical cancer screening.
PMV Pharmaceuticals is a developer of p53-targeted small molecule drugs for the treatment of cancer.
Perfuse Therapeutics specializes in developing therapies for the treatment of eye disease.
New Horizon Health is a bio-tech company focusing on early screening and genetic testing services for high-incidence cancer homes.
Pionyr Immunotherapeutics is a developer of cancer immunotherapies designed to target the tumor microenvironment.
MabPlex provides CDMO services in the development and manufacturing of biopharmaceuticals.
Norson Biotechnology produces edible probiotic powders, fermented lactic acid bacteria beverages, and other products.
Protekt Therapeutics is a drug development company aiming to develop inhibitors of PKR for various diseases
GrayBug is a biopharmaceutical company that develops transformative medicines for ocular diseases.
Cleave Therapeutics is focused on protein homeostasis and stress pathways in cancer and neurodegeneration.
Prevail Therapeutics is a biotechnology company focused on developing novel gene therapies for patients with Parkinson’s disease.
resTORbio is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics.
Peloton Therapeutics, a biotech company based in Dallas, is involved in discovering and developing novel drugs for cancer treatments.
Modis Therapeutics is bringing disease-modifying therapies to patients with rare genetic diseases.
Bsense Bio Therapeutics develops small molecules for the treatment of sensory hyperexcitability related disorders.
KaNDy Therapeutics is a clinical-stage company focused on optimizing the potential of NT-814.
Therachon is a global biotechnology company focused on developing medicines for rare, genetic diseases
ARMO Biosciences is a biotechnology company that develops immune modulatory biologic therapeutics.
True North Therapeutics is a pioneering biotechnology company selectively inhibiting the Complement pathway for diseases.
Tisbury Pharmaceuticals is a pre-clinical stage pharmaceutical company.
Rhythm Metabolic develops a novel peptide MC4 agonist for the treatment of obesity caused by genetic deficiencies.
Seragon Pharmaceuticals is a research-based company dedicated to improving human and animal health through innovative science.
Angelalign is a global service provider of invisible orthodontic technology and invisible orthodontics production and sales.
Arteaus Therapeutics is a biotechnology development company focused on creating new therapies to treat migraine.
OrbiMed has invested in 289 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
OrbiMed's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Pharmaceutical. The firm invests across 20 different industry categories.
Among tracked funding rounds, Pionyr Immunotherapeutics received $275.0M in a Corporate Round round. OrbiMed's total known invested capital is $23.6B.
OrbiMed's average investment size is $104.0M across its portfolio of 289 companies.
Recent OrbiMed portfolio additions include MobileODT, PMV Pharmaceuticals, Perfuse Therapeutics, New Horizon Health, Pionyr Immunotherapeutics. These companies were founded in 2020 or later.